A model of a gp120 V3 peptide in complex with an HIV-neutralizing antibody based on NMR and mutant cycle-derived constraints.
Zvi A, Tugarinov V, Faiman GA, Horovitz A, Anglister J.
Zvi A, et al. Among authors: tugarinov v.
Eur J Biochem. 2000 Feb;267(3):767-79. doi: 10.1046/j.1432-1327.2000.01055.x.
Eur J Biochem. 2000.
PMID: 10651813
Free article.
The peptide converges to a unique position within the binding site, with the RGPG loop pointing into the center of the groove formed by the antibody complementary determining regions while retaining the beta-hairpin conformation and the type-VI RGPG turn [Tugarinov, V …
The peptide converges to a unique position within the binding site, with the RGPG loop pointing into the center of the groove formed by the …